Site-dependent small intestinal absorption of ranitidine T Gramatté, E El Desoky, U Klotz European journal of clinical pharmacology 46, 253-259, 1994 | 88 | 1994 |
Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients ES El Desoky, E Fuseau, S EL Din Amry, V Cosson European journal of clinical pharmacology 59, 783-790, 2004 | 41 | 2004 |
Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients MS Hareedy, ES El Desoky, JB Woillard, RH Thabet, AM Ali, P Marquet, ... Pharmacogenomics 16 (10), 1119-1134, 2015 | 40 | 2015 |
Pharmacotherapy of rheumatoid arthritis: an overview ES El Desoky Current therapeutic research 62 (2), 92-112, 2001 | 39 | 2001 |
Generation of pharmacokinetic data during routine therapeutic drug monitoring: Bayesian approach vs. pharmacokinetic studies E El Desoky, J Meinshausen, K Bühl, G Engel, A Harings-Kaim, ... Therapeutic drug monitoring 15 (4), 281-288, 1993 | 39 | 1993 |
Study of urinary 6β-hydroxycortisol/cortisol ratio in spot urine sample as a biomarker of 3A4 enzyme activity in healthy and epileptic subjects of Egyptian population ES El Desoky, HO Mohamed, WMA Farghaly, SA Hamed, MA Hedaya, ... Pharmacological research 51 (6), 575-580, 2005 | 32 | 2005 |
Population pharmacokinetics of steady‐state carbamazepine in Egyptian epilepsy patients ES El Desoky, SN Sabarinath, MM Hamdi, M Bewernitz, H Derendorf Journal of clinical pharmacy and therapeutics 37 (3), 352-355, 2012 | 26 | 2012 |
Drug therapy of heart failure: an immunologic view ES El Desoky American journal of therapeutics 18 (5), 416-425, 2011 | 26 | 2011 |
NAT2* 5/* 5 genotype (341T> C) is a potential risk factor for schistosomiasis-associated bladder cancer in Egyptians ES El Desoky, YM AbdelSalam, RH Salama, MA El Akkad, S Atanasova, ... Therapeutic drug monitoring 27 (3), 297-304, 2005 | 25 | 2005 |
Some international approaches to aminoglycoside monitoring in the extended dosing interval era RG Morris, BC Sallustio, AA Vinks, DF LeGatt, ZH Verjee, E El Desoky Therapeutic drug monitoring 21 (4), 379-388, 1999 | 22 | 1999 |
Aminoglycoside and vancomycin serum concentration monitoring and mortality due to neonatal sepsis in Saudi Arabia ES El Desoky, AA Sheikh, AY Al Hammadi Journal of clinical pharmacy and therapeutics 28 (6), 479-483, 2003 | 12 | 2003 |
The AMPA receptor antagonist perampanel is a new hope in the treatment for epilepsy ES El Desoky Fundamental & clinical pharmacology 28 (5), 473-480, 2014 | 9 | 2014 |
Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy E EL DESOKY, MR KANDIL, AHM AFIFI, OA MOSTAFA Pharmacological research 39 (4), 269-274, 1999 | 9 | 1999 |
Disposition of intravenous theophylline in asthmatic children: Bayesian approach vs direct pharmacokinetic calculations DE El, HG Mohamed, AM Moussa, K Ulrich Japanese journal of pharmacology 75 (1), 13-20, 1997 | 8 | 1997 |
Value, limitations and clinical impact of therapeutic drug monitoring in adults DE El Desoky, U Klotz Drug Investigation 6, 127-136, 1993 | 8 | 1993 |
The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin‐induced anaemia in chronic hepatitis C Egyptian patients ES El Desoky, AT Abdelhafez, J Cusato, SI Kamel, AMR Hussein, ... Clinical and Experimental Pharmacology and Physiology 44 (9), 965-968, 2017 | 6 | 2017 |
Pharmacokinetics and pharmacodynamics of famotidine in patients with reflux oesophagitis U Gladziwa, S Wagner, KV Dakshinamurty, EE Desoky, B Dreuw, U Klotz European journal of clinical pharmacology 44, 357-360, 1993 | 6 | 1993 |
Amphetamine versus non amphetamine-related first episode psychosis in Saudi Arabian patients ESEL Desoky, AMA El-Tantawy, YM Raya, A Al-Yahya Pharmacology & Pharmacy 2 (03), 101, 2011 | 5 | 2011 |
Genetic analysis of leucin-rich repeat kinase 2 (LRRK2) G2019S mutation in a sample of Egyptian patients with Parkinson's disease, a pilot study. ES El-Desoky, EM Khedr, MS Khalil, T Gasser | 4 | 2014 |
Deprescription in elderly: A spotlight on pharmacoeconomic aspect. ESEL Desoky Clin Exp Pharmacol Physio 47 (2), 333-336, 2020 | 3 | 2020 |